{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:02:46Z","timestamp":1787320966483,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["CAS21\/00269"],"award-info":[{"award-number":["CAS21\/00269"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG 2020 \u2013 ID 24454"],"award-info":[{"award-number":["IG 2020 \u2013 ID 24454"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002911","name":"Universidad Complutense de Madrid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002911","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Brain drug delivery is severely hindered by the presence of the blood\u2013brain barrier (BBB)\n                    <jats:italic>.<\/jats:italic>\n                    Its functionality relies on the interactions of the brain endothelial cells with additional cellular constituents, including pericytes, astrocytes, neurons, or microglia. To boost brain drug delivery, nanomedicines have been designed to exploit distinct delivery strategies, including magnetically driven nanocarriers as a form of external physical targeting to the BBB. Herein, a lipid-based magnetic nanocarrier prepared by a low-energy method is first described. Magnetic nanocapsules with a hydrodynamic diameter of 256.7\u2009\u00b1\u20098.5\u00a0nm (polydispersity index: 0.089\u2009\u00b1\u20090.034) and a \u03be-potential of -30.4\u2009\u00b1\u20090.3\u00a0mV were obtained. Transmission electron microscopy-energy dispersive X-ray spectroscopy analysis revealed efficient encapsulation of iron oxide nanoparticles within the oily core of the nanocapsules. Both thermogravimetric analysis and phenanthroline-based colorimetric assay showed that the iron oxide percentage in the final formulation was 12 wt.%, in agreement with vibrating sample magnetometry analysis, as the specific saturation magnetization of the magnetic nanocapsules was 12% that of the bare iron oxide nanoparticles. Magnetic nanocapsules were non-toxic in the range of 50\u2013300\u00a0\u03bcg\/mL over 72\u00a0h against both the human cerebral endothelial hCMEC\/D3 and Human Brain Vascular Pericytes cell lines. Interestingly, higher uptake of magnetic nanocapsules in both cell types was evidenced in the presence of an external magnetic field than in the absence of it after 24\u00a0h. This increase in nanocapsules uptake was also evidenced in pericytes after only 3\u00a0h. Altogether, these results highlight the potential for magnetic targeting to the BBB of our formulation.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s13346-024-01587-w","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:02:33Z","timestamp":1715590953000},"page":"3494-3511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Development and characterization of lipid nanocapsules loaded with iron oxide nanoparticles for magnetic targeting to the blood\u2013brain barrier"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-4568","authenticated-orcid":false,"given":"Juan","family":"Aparicio-Blanco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"De Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriana","family":"Debellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Ciofani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"1587_CR1","doi-asserted-by":"publisher","first-page":"114816","DOI":"10.1016\/j.addr.2023.114816","volume":"196","author":"A P\u00e9rez-L\u00f3pez","year":"2023","unstructured":"P\u00e9rez-L\u00f3pez A, Torres-Su\u00e1rez AI, Mart\u00edn-Sabroso C, Aparicio-Blanco J. An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines. Adv Drug Deliv Rev. 2023;196:114816.","journal-title":"Adv Drug Deliv Rev"},{"key":"1587_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, Meyer AH, Bell RD, Zhang WD. Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov. 2021;20:362\u201383.","journal-title":"Nat Rev Drug Discov"},{"key":"1587_CR3","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","volume":"11","author":"L Han","year":"2021","unstructured":"Han L, Jiang C. Evolution of blood\u2013brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharmaceutica Sinica B. 2021;11:2306\u201325.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"1587_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.actbio.2018.04.029","volume":"73","author":"J Aparicio-Blanco","year":"2018","unstructured":"Aparicio-Blanco J, Torres-Suarez AI. Towards tailored management of malignant brain tumors with nanotheranostics. Acta Biomater. 2018;73:52\u201363.","journal-title":"Acta Biomater"},{"key":"1587_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2020.06.010","volume":"158","author":"T Sun","year":"2020","unstructured":"Sun T, Dasgupta A, Zhao ZM, Nurunnabi M, Mitragotri S. Physical triggering strategies for drug delivery. Adv Drug Deliv Rev. 2020;158:36\u201362.","journal-title":"Adv Drug Deliv Rev"},{"key":"1587_CR6","first-page":"13","volume":"9","author":"BY Li","year":"2022","unstructured":"Li BY, Chen X, Qiu W, Zhao RR, Duan JZ, Zhang SJ, Pan ZW, Zhao SL, Guo QD, Qi YH, Wang WH, Deng L, Ni SL, Sang YH, Xue H, Liu H, Li G. Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy. Adv Sci. 2022;9:13.","journal-title":"Adv Sci"},{"key":"1587_CR7","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1021\/acsbiomaterials.9b00856","volume":"5","author":"R Afzalipour","year":"2019","unstructured":"Afzalipour R, Khoei S, Khoee S, Shirvalilou S, Raoufi NJ, Motevalian M, Karimi MR. Dual-targeting temozolomide loaded in folate-conjugated magnetic triblock copolymer nanoparticles to improve the therapeutic efficiency of rat brain gliomas. ACS Biomater Sci Eng. 2019;5:6000\u201311.","journal-title":"ACS Biomater Sci Eng"},{"key":"1587_CR8","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.2147\/IJN.S165184","volume":"13","author":"LP Ganipineni","year":"2018","unstructured":"Ganipineni LP, Ucakar B, Joudiou N, Bianco J, Danhier P, Zhao MN, Bastiancich C, Gallez B, Danhier F, Pr\u00e9at V. Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma. Int J Nanomed. 2018;13:4509\u201321.","journal-title":"Int J Nanomed"},{"key":"1587_CR9","doi-asserted-by":"publisher","first-page":"32159","DOI":"10.1021\/acsami.6b10175","volume":"8","author":"Y Cui","year":"2016","unstructured":"Cui Y, Zhang M, Zeng F, Jin HY, Xu Q, Huang YZ. Dual-targeting magnetic PLGA nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. ACS Appl Mater Interfaces. 2016;8:32159\u201369.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1587_CR10","doi-asserted-by":"publisher","first-page":"14222","DOI":"10.1039\/C6NR02448C","volume":"8","author":"HL Xu","year":"2016","unstructured":"Xu HL, Mao KL, Huang YP, Yang JJ, Xu J, Chen PP, Fan ZL, Zou S, Gao ZZ, Yin JY, Xiao J, Lu CT, Zhang BL, Zhao YZ. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects. Nanoscale. 2016;8:14222\u201336.","journal-title":"Nanoscale"},{"key":"1587_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biomaterials.2023.122320","volume":"302","author":"R Shi","year":"2023","unstructured":"Shi R, Lv R, Dong ZL, Cao QH, Wu RF, Liu SD, Ren YJ, Liu Z, van der Mei HC, Liu J, Busscher HJ. Magnetically-targetable outer-membrane vesicles for sonodynamic eradication of antibiotic-tolerant bacteria in bacterial meningitis. Biomaterials. 2023;302:14.","journal-title":"Biomaterials"},{"key":"1587_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jconrel.2022.12.006","volume":"353","author":"M Azarmi","year":"2023","unstructured":"Azarmi M, Maleki H, Nikkam N, Malekinejad H. Novel neurolisteriosis therapy using SPION as a drivable nanocarrier in gallic acid delivery to CNS. J Control Release. 2023;353:507\u201317.","journal-title":"J Control Release"},{"key":"1587_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.addr.2023.114822","volume":"197","author":"RR Qiao","year":"2023","unstructured":"Qiao RR, Fu CK, Forgham H, Javed I, Huang XM, Zhu JY, Whittaker AK, Davis TP. Magnetic iron oxide nanoparticles for brain imaging and drug delivery. Adv Drug Deliv Rev. 2023;197:31.","journal-title":"Adv Drug Deliv Rev"},{"key":"1587_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2020.01.009","volume":"320","author":"LL Israel","year":"2020","unstructured":"Israel LL, Galstyan A, Holler E, Ljubimova JY. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. J Control Release. 2020;320:45\u201362.","journal-title":"J Control Release"},{"key":"1587_CR15","first-page":"25","volume":"23","author":"F D'Agata","year":"2018","unstructured":"D\u2019Agata F, Ruffinatti FA, Boschi S, Stura I, Rainero I, Abollino O, Cavalli R, Guiot C. Magnetic nanoparticles in the central nervous system: targeting principles. Appl Saf Issues, Molecules. 2018;23:25.","journal-title":"Appl Saf Issues, Molecules"},{"key":"1587_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","volume":"138","author":"SM Dadfar","year":"2019","unstructured":"Dadfar SM, Roemhild K, Drude NI, von Stillfried S, Kn\u00fcchel R, Kiessling F, Lammers T. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019;138:302\u201325.","journal-title":"Adv Drug Deliv Rev"},{"key":"1587_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.msec.2019.03.004","volume":"100","author":"Z Karami","year":"2019","unstructured":"Karami Z, Sadighian S, Rostamizadeh K, Hosseini SH, Rezaee S, Hamidi M. Magnetic brain targeting of naproxen-loaded polymeric micelles: pharmacokinetics and biodistribution study. Mater Sci Eng C-Mater Biol Appl. 2019;100:771\u201380.","journal-title":"Mater Sci Eng C-Mater Biol Appl"},{"key":"1587_CR18","first-page":"10","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J, Zhu X, Li C, Cai L, Pei W, Ni M, He J, Jiang H, Chen J. Efficient exosome extraction through the conjugation of superparamagnetic iron oxide nanoparticles for the targeted delivery in rat brain. Mater Today Chem. 2022;23:10.","journal-title":"Mater Today Chem"},{"key":"1587_CR19","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1021\/acs.nanolett.6b02261","volume":"16","author":"KT Al-Jamal","year":"2016","unstructured":"Al-Jamal KT, Bai J, Wang JT-W, Protti A, Southern P, Bogart L, Heidari H, Li X, Cakebread A, Asker D, Al-Jamal WT, Shah A, Bals S, Sosabowski J, Pankhurst QA. Magnetic Drug Targeting: Preclinical in Vivo Studies, Mathematical Modeling, and Extrapolation to Humans. Nano Lett. 2016;16:5652\u201360.","journal-title":"Nano Lett"},{"key":"1587_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jconrel.2020.03.042","volume":"322","author":"RP Moura","year":"2020","unstructured":"Moura RP, Pacheco C, Pego AP, Rieux des A, Sarmento B. Lipid nanocapsules to enhance drug bioavailability to the central nervous system. J Control Release. 2020;322:390\u2013400.","journal-title":"J Control Release"},{"key":"1587_CR21","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1021\/acs.molpharmaceut.8b01344","volume":"16","author":"J Aparicio-Blanco","year":"2019","unstructured":"Aparicio-Blanco J, Romero IA, Male DK, Slowing K, Garcia-Garcia L, Torres-Suarez AI. Cannabidiol enhances the passage of lipid nanocapsules across the blood-brain barrier both in vitro and in Vivo. Mol Pharm. 2019;16:1999\u20132010.","journal-title":"Mol Pharm"},{"key":"1587_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1023\/A:1016121319668","volume":"19","author":"B Heurtault","year":"2002","unstructured":"Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 2002;19:875\u201380.","journal-title":"Pharm Res"},{"key":"1587_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-023-01310-0","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen XJ, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:27.","journal-title":"Signal Transduct Target Ther"},{"key":"1587_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1166\/jbn.2019.2765","volume":"15","author":"J Aparicio-Blanco","year":"2019","unstructured":"Aparicio-Blanco J, Sebastian V, Rodriguez-Amaro M, Garcia-Diaz HC, Torres-Suarez AI. Size-tailored design of highly monodisperse lipid nanocapsules for drug delivery. J Biomed Nanotechnol. 2019;15:1149\u201361.","journal-title":"J Biomed Nanotechnol"},{"key":"1587_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.scriptamat.2010.04.019","volume":"63","author":"C Gammer","year":"2010","unstructured":"Gammer C, Mangler C, Rentenberger C, Karnthaler HP. Quantitative local profile analysis of nanomaterials by electron diffraction. Scr Mater. 2010;63:312\u20135.","journal-title":"Scr Mater"},{"key":"1587_CR26","first-page":"23","volume":"12","author":"D De Pasquale","year":"2023","unstructured":"De Pasquale D, Pucci C, Desii A, Marino A, Debellis D, Leoncino L, Prato M, Moscato S, Amadio S, Fiaschi P, Prior A, Ciofani G. A novel patient-personalized nanovector based on homotypic recognition and magnetic hyperthermia for an efficient treatment of glioblastoma multiforme. Adv Healthc Mater. 2023;12:23.","journal-title":"Adv Healthc Mater"},{"key":"1587_CR27","doi-asserted-by":"publisher","first-page":"29037","DOI":"10.1021\/acsami.0c05556","volume":"12","author":"C Pucci","year":"2020","unstructured":"Pucci C, De Pasquale D, Marino A, Martinelli C, Lauciello S, Ciofani G. Hybrid magnetic nanovectors promote selective glioblastoma cell death through a combined effect of lysosomal membrane permeabilization and chemotherapy. ACS Appl Mater Interfaces. 2020;12:29037\u201355.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1587_CR28","doi-asserted-by":"publisher","first-page":"21227","DOI":"10.1039\/C9NR07976A","volume":"11","author":"A Marino","year":"2019","unstructured":"Marino A, Camponovo A, Degl\u2019Innocenti A, Bartolucci M, Tapeinos C, Martinelli C, De Pasquale D, Santoro F, Mollo V, Arai S, Suzuki M, Harada Y, Petretto A, Ciofani G. Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment. Nanoscale. 2019;11:21227\u201348.","journal-title":"Nanoscale"},{"key":"1587_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1039\/C8NR05520C","volume":"11","author":"C Tapeinos","year":"2019","unstructured":"Tapeinos C, Marino A, Battaglini M, Migliorin S, Brescia R, Scarpellini A, Fern\u00e1ndez CD, Prato M, Drago F, Ciofani G. Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy. Nanoscale. 2019;11:72\u201388.","journal-title":"Nanoscale"},{"key":"1587_CR30","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2217\/nnm-2017-0393","volume":"13","author":"D Zhao","year":"2018","unstructured":"Zhao D, Chen Q, Song H, Luo ST, Ge PY, Wang YJ, Ma JY, Li Z, Gao XM, Zhao XM, Subinuer X, Yang HY, Jiang XJ, Chen YX, Zhu X. Theranostic micelles combined with multiple strategies to effectively overcome multidrug resistance. Nanomedicine. 2018;13:1517\u201333.","journal-title":"Nanomedicine"},{"key":"1587_CR31","doi-asserted-by":"publisher","first-page":"6967","DOI":"10.1039\/C4TB01273A","volume":"2","author":"A Topete","year":"2014","unstructured":"Topete A, Melgar D, Alatorre-Meda M, Iglesias P, Argibay B, Vidawati S, Barbosa S, Costoya JA, Taboada P, Mosquera V. NIR-light active hybrid nanoparticles for combined imaging and bimodal therapy of cancerous cells. J Mat Chem B. 2014;2:6967\u201377.","journal-title":"J Mat Chem B"},{"key":"1587_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijpharm.2013.02.042","volume":"447","author":"N Schleich","year":"2013","unstructured":"Schleich N, Sibret P, Danhier P, Ucakar B, Laurent S, Muller RN, J\u00e9r\u00f4me C, Gallez B, Pr\u00e9at V, Danhier F. Dual anticancer drug\/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Int J Pharm. 2013;447:94\u2013101.","journal-title":"Int J Pharm"},{"key":"1587_CR33","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.2147\/IJN.S62260","volume":"9","author":"ZZ Sun","year":"2014","unstructured":"Sun ZZ, Worden M, Wroczynskyj Y, Yathindranath V, van Lierop J, Hegmann T, Miller DW. Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier. Int J Nanomed. 2014;9:3013\u201326.","journal-title":"Int J Nanomed"},{"key":"1587_CR34","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1107\/S0567740881004597","volume":"37","author":"ME Fleet","year":"1981","unstructured":"Fleet ME. The structure of magnetite. Acta Crystallogr Sect B-Struct Commun. 1981;37:917\u201320.","journal-title":"Acta Crystallogr Sect B-Struct Commun"},{"key":"1587_CR35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/aps.2017.45","volume":"38","author":"YN Cui","year":"2017","unstructured":"Cui YN, Xu QX, Davoodi P, Wang DP, Wang CH. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin. Acta Pharmacol Sin. 2017;38:943\u201353.","journal-title":"Acta Pharmacol Sin"},{"key":"1587_CR36","doi-asserted-by":"publisher","first-page":"15996","DOI":"10.1021\/acsomega.2c01136","volume":"7","author":"Y Hadadian","year":"2022","unstructured":"Hadadian Y, Masoomi H, Dinari A, Ryu C, Hwang S, Kim S, Cho BK, Lee JY, Yoon J. From low to high saturation magnetization in magnetite nanoparticles: the crucial role of the molar ratios between the chemicals. ACS Omega. 2022;7:15996\u20136012.","journal-title":"ACS Omega"},{"key":"1587_CR37","doi-asserted-by":"publisher","first-page":"77452","DOI":"10.1039\/C6RA12072E","volume":"6","author":"SJ Kemp","year":"2016","unstructured":"Kemp SJ, Ferguson RM, Khandhar AP, Krishnan KM. Monodisperse magnetite nanoparticles with nearly ideal saturation magnetization. RSC Adv. 2016;6:77452\u201364.","journal-title":"RSC Adv"},{"key":"1587_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jmmm.2022.169140","volume":"551","author":"O Karaagac","year":"2022","unstructured":"Karaagac O, K\u00f6\u00e7kar H. Improvement of the saturation magnetization of PEG coated superparamagnetic iron oxide nanoparticles. J Magn Magn Mater. 2022;551:8.","journal-title":"J Magn Magn Mater"},{"key":"1587_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pcrysgrow.2008.08.003","volume":"55","author":"AS Teja","year":"2009","unstructured":"Teja AS, Koh PY. Synthesis, properties, and applications of magnetic iron oxide nanoparticles. Prog Cryst Growth Charact Mater. 2009;55:22\u201345.","journal-title":"Prog Cryst Growth Charact Mater"},{"key":"1587_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jmmm.2006.07.037","volume":"309","author":"J Xu","year":"2007","unstructured":"Xu J, Yang HB, Fu WY, Du K, Sui YM, Chen JJ, Zeng Y, Li MH, Zou G. Preparation and magnetic properties of magnetite nanoparticles by sol-gel method. J Magn Magn Mater. 2007;309:307\u201311.","journal-title":"J Magn Magn Mater"},{"key":"1587_CR41","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/anie.200602866","volume":"46","author":"AH Lu","year":"2007","unstructured":"Lu AH, Salabas EL, Sch\u00fcth F. Magnetic nanoparticles: Synthesis, protection, functionalization, and application. Angew Chem-Int Edit. 2007;46:1222\u201344.","journal-title":"Angew Chem-Int Edit"},{"key":"1587_CR42","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1021\/acsomega.8b00152","volume":"3","author":"GB Heggannavar","year":"2018","unstructured":"Heggannavar GB, Hiremath CG, Achari DD, Pangarkar VG, Kariduraganavar MY. Development of doxorubicin-loaded magnetic silica-pluronic F-127 nanocarriers conjugated with transferrin for treating glioblastoma across the blood-brain barrier using an in vitro model. ACS Omega. 2018;3:8017\u201326.","journal-title":"ACS Omega"},{"key":"1587_CR43","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.3390\/ijms16048070","volume":"16","author":"J Estelrich","year":"2015","unstructured":"Estelrich J, Escribano E, Queralt J, Busquets MA. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int J Mol Sci. 2015;16:8070\u2013101.","journal-title":"Int J Mol Sci"},{"key":"1587_CR44","doi-asserted-by":"publisher","first-page":"12707","DOI":"10.1021\/acsomega.0c00163","volume":"5","author":"G Micheletti","year":"2020","unstructured":"Micheletti G, Boga C, Telese D, Cassani MC, Boanini E, Nitti P, Ballarin B, Ghirri A, Barucca G, Rinaldi D. Magnetic nanoparticles coated with (R)-9-acetoxystearic acid for biomedical applications. ACS Omega. 2020;5:12707\u201315.","journal-title":"ACS Omega"},{"key":"1587_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jconrel.2013.06.014","volume":"170","author":"G Bastiat","year":"2013","unstructured":"Bastiat G, Pritz CO, Roider C, Fouchet F, Ligni\u00e8res E, Jesacher A, Glueckert R, Ritsch-Marte M, Schrott-Fischer A, Saulnier P, Benoit JP. A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging. J Control Release. 2013;170:334\u201342.","journal-title":"J Control Release"},{"key":"1587_CR46","doi-asserted-by":"publisher","first-page":"18441","DOI":"10.1021\/acsnano.3c06085","volume":"17","author":"L Beola","year":"2023","unstructured":"Beola L, Iturrioz-Rodr\u00edguez N, Pucci C, Bertorelli R, Ciofani G. Drug-loaded lipid magnetic nanoparticles for combined local hyperthermia and chemotherapy against glioblastoma multiforme. ACS Nano. 2023;17:18441.","journal-title":"ACS Nano"},{"key":"1587_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpharm.2022.122341","volume":"628","author":"E Bozzato","year":"2022","unstructured":"Bozzato E, Tsakiris N, Paquot A, Muccioli GG, Bastiancich C, Preat V. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells. Int J Pharm. 2022;628:12.","journal-title":"Int J Pharm"},{"key":"1587_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpharm.2019.118795","volume":"573","author":"ML Formica","year":"2020","unstructured":"Formica ML, Gamboa GVU, Tartara LI, Luna JD, Benoit JP, Palma SD. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications. Int J Pharm. 2020;573:12.","journal-title":"Int J Pharm"},{"key":"1587_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejpb.2018.11.020","volume":"134","author":"J Aparicio-Blanco","year":"2019","unstructured":"Aparicio-Blanco J, Sebastian V, Benoit JP, Torres-Suarez AI. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters. Eur J Pharm Biopharm. 2019;134:126\u201337.","journal-title":"Eur J Pharm Biopharm"},{"key":"1587_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijpharm.2020.119433","volume":"585","author":"MS Bohley","year":"2020","unstructured":"Bohley MS, Birch E, Baumann FJ, Dillinger AE, Tamm ER, Goepferich AM. Design of dye and superparamagnetic iron oxide nanoparticle loaded lipid nanocapsules with dual detectability in vitro and in vivo. Int J Pharm. 2020;585:7.","journal-title":"Int J Pharm"},{"key":"1587_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2023.04.034","volume":"358","author":"RP Moura","year":"2023","unstructured":"Moura RP, Carvalho ED, Martins C, des Rieux A, P\u00eago AP, Sarmento B. Functionalized retinoic acid lipid nanocapsules promotes a two-front attack on inflammation and lack of demyelination on neurodegenerative disorders. J Control Release. 2023;358:43\u201358.","journal-title":"J Control Release"},{"key":"1587_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1126\/sciadv.abo6638","volume":"8","author":"M Bohley","year":"2022","unstructured":"Bohley M, Dillinger AE, Schweda F, Ohlmann A, Braunger BM, Tamm ER, Goepferich A. A single intravenous injection of cyclosporin A-loaded lipid nanocapsules prevents retinopathy of prematurity. Sci Adv. 2022;8:13.","journal-title":"Sci Adv"},{"key":"1587_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biomaterials.2019.119653","volume":"230","author":"D Carradori","year":"2020","unstructured":"Carradori D, Labrak Y, Miron VE, Saulnier P, Eyer J, Preat V, des Rieux A. Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal white matter lesion. Biomaterials. 2020;230:11.","journal-title":"Biomaterials"},{"key":"1587_CR54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jconrel.2016.01.054","volume":"225","author":"C Bastiancich","year":"2016","unstructured":"Bastiancich C, Vanvarenberg K, Ucakar B, Pitorre M, Bastiat G, Lagarce F, Preat V, Danhier F. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma. J Control Release. 2016;225:283\u201393.","journal-title":"J Control Release"},{"key":"1587_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2217\/nnm-2018-0436","volume":"14","author":"A Grillone","year":"2019","unstructured":"Grillone A, Battaglini M, Moscato S, Mattii L, Fern\u00e1ndez CD, Scarpellini A, Giorgi M, Sinibaldi E, Ciofani G. Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment. Nanomedicine. 2019;14:727\u201352.","journal-title":"Nanomedicine"},{"key":"1587_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpharm.2014.08.035","volume":"475","author":"MY Zhao","year":"2014","unstructured":"Zhao MY, Hu J, Zhang LN, Zhang L, Sun YJ, Ma N, Chen XL, Gao ZB. Study of amphotericin B magnetic liposomes for brain targeting. Int J Pharm. 2014;475:9\u201316.","journal-title":"Int J Pharm"},{"key":"1587_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jconrel.2014.07.059","volume":"194","author":"N Schleich","year":"2014","unstructured":"Schleich N, Po C, Jacobs D, Ucakar B, Gallez B, Danhier F, Pr\u00e9at V. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel\/SPIO-loaded nanoparticles for tumor imaging and therapy. J Control Release. 2014;194:82\u201391.","journal-title":"J Control Release"},{"key":"1587_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1021\/acs.molpharmaceut.7b00742","volume":"15","author":"YN Xu","year":"2018","unstructured":"Xu YN, Carradori D, Alhouayek M, Muccioli GG, Cani PD, Preat V, Beloqui A. Size effect on lipid nanocapsule-mediated GLP-1 secretion from enteroendocrine L cells. Mol Pharm. 2018;15:108\u201315.","journal-title":"Mol Pharm"},{"key":"1587_CR59","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ajps.2020.07.005","volume":"16","author":"J Di","year":"2021","unstructured":"Di J, Gao X, Du Y, Zhang H, Gao J, Zheng A. Size, shape, charge and \u201cstealthy\u201d surface: Carrier properties affect the drug circulation time in vivo. Asian J Pharm Sci. 2021;16:444\u201358.","journal-title":"Asian J Pharm Sci"},{"key":"1587_CR60","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","volume":"235","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee S. DLS and zeta potential - What they are and what they are not? J Control Release. 2016;235:337\u201351.","journal-title":"J Control Release"},{"key":"1587_CR61","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1039\/C9BM00178F","volume":"7","author":"RR Li","year":"2019","unstructured":"Li RR, Wang J, Yu XY, Xu PF, Zhang S, Xu JH, Bai YJ, Dai ZZ, Sun YX, Ye RD, Liu XF, Ruan G, Xu GL. Enhancing the effects of transcranial magnetic stimulation with intravenously injected magnetic nanoparticles. Biomater Sci. 2019;7:2297\u2013307.","journal-title":"Biomater Sci"},{"key":"1587_CR62","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.7150\/thno.15297","volume":"6","author":"CH Fan","year":"2016","unstructured":"Fan CH, Cheng YH, Ting CY, Ho YJ, Hsu PH, Liu HL, Yeh CK. Ultrasound\/magnetic targeting with SPIO-DOX-microbubble complex for image-guided drug delivery in brain tumors. Theranostics. 2016;6:1542\u201356.","journal-title":"Theranostics"},{"key":"1587_CR63","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.1016\/j.biomaterials.2013.07.075","volume":"34","author":"YN Cui","year":"2013","unstructured":"Cui YN, Xu QX, Chow PKH, Wang DP, Wang CH. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials. 2013;34:8511\u201320.","journal-title":"Biomaterials"},{"key":"1587_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11671-016-1676-2","volume":"11","author":"XQ Zhao","year":"2016","unstructured":"Zhao XQ, Shang T, Zhang XD, Ye T, Wang DJ, Rei L. Passage of magnetic tat-conjugated Fe3O4@SiO2 nanoparticles across in vitro blood-brain barrier. Nanoscale Res Lett. 2016;11:12.","journal-title":"Nanoscale Res Lett"},{"key":"1587_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/nano10030477","volume":"10","author":"M Norouzi","year":"2020","unstructured":"Norouzi M, Yathindranath V, Thliveris JA, Miller DW. Salinomycin-loaded iron oxide nanoparticles for glioblastoma therapy. Nanomaterials. 2020;10:21.","journal-title":"Nanomaterials"},{"key":"1587_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41598-020-68017-y","volume":"10","author":"M Norouzi","year":"2020","unstructured":"Norouzi M, Yathindranath V, Thliveris JA, Kopec BM, Siahaan TJ, Miller DW. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Sci Rep. 2020;10:18.","journal-title":"Sci Rep"},{"key":"1587_CR67","doi-asserted-by":"publisher","unstructured":"Mwema A, Gratpain V, Ucakar B, Vanvarenberg K, Perdaens O, van Pesch V, Muccioli GG, des Rieux A. Impact of calcitriol and PGD2-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination. Drug Deliv Transl Res. 2024. https:\/\/doi.org\/10.1007\/s13346-024-01535-8.","DOI":"10.1007\/s13346-024-01535-8"},{"key":"1587_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nano.2022.102633","volume":"48","author":"A Mwema","year":"2023","unstructured":"Mwema A, Bottemanne P, Paquot A, Ucakar B, Vanvarenberg K, Alhouayek M, Muccioli GG, des Rieux A. Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G. Nanomed-Nanotechnol Biol Med. 2023;48:15.","journal-title":"Nanomed-Nanotechnol Biol Med"},{"key":"1587_CR69","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1016\/j.biomaterials.2013.01.068","volume":"34","author":"J Balzeau","year":"2013","unstructured":"Balzeau J, Pinier M, Berges R, Saulnier P, Benoit J-P, Eyer J. The effect of functionalizing lipid nanocapsules with NFL-TBS.40\u201363 peptide on their uptake by glioblastoma cells. Biomaterials. 2013;34:3381\u20139.","journal-title":"Biomaterials"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01587-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01587-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01587-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T11:11:40Z","timestamp":1729681900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01587-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01587-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"25 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}